Lesion size reduction in mouse model of endometriosis following clove (Syzygium aromaticum) leaf extract administration: An experimental study

article OA: gold CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-07-17

Administration of clove leaf extract to a mouse endometriosis model reduced lesion size without altering VEGF or BDNF levels, suggesting an unknown mechanism of action.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-13 · read from full text

This experimental study investigated the therapeutic potential of Syzygium aromaticum leaf extract in a mouse model of surgically induced endometriosis. Researchers administered the clove leaf extract to mice and subsequently measured changes in lesion size compared to control groups to evaluate its efficacy. The results demonstrated a significant reduction in the volume of endometriotic lesions following treatment, indicating that the extract possesses anti-endometriotic properties in this animal model. This paper is centrally about endometriosis — specifically evaluating the effect of a natural plant extract on lesion regression in an established murine model.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis affects about 10% of reproductive-age women, causing pelvic pain and infertility. Its progression involves angiogenesis and neurovascular innervation, mediated by vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF). Clove leaf extract may suppress lesion growth by reducing these pathways through antioxidant and anti-inflammatory actions. OBJECTIVE: This study evaluated clove leaf extract's impact on VEGF and BDNF pathways and lesion size in female mice with endometriosis, testing whether extract reduces VEGF, BDNF, and lesion area, with the hypothesis that intermediate dosage provides optimal efficacy. MATERIALS AND METHODS: A total of 36 female BALB/c mouse endometriosis model (2-3 months old, weighing 20-30 gr) induced by uterine endometrial implantation with estrogen supplementation were randomly assigned to 4 groups: one untreated control group (K⁺) and 3 treatment groups receiving clove leaf extract at doses of 75 mg/kg-BW (P1), 150 mg/kg-BW (P2), and 300 mg/kg-BW (P3). Blood samples and peritoneal tissue were collected for analysis using commercial Enzyme-Linked Immunosorbent Assay kits targeting VEGF and BDNF, as well as Motic imaging for lesion assessment. RESULTS: Following 14 days of clove leaf extract administration, endometriosis lesion area significantly decreased (p = 0.001), whereas VEGF (p = 0.27) and BDNF (p = 0.13) remained unchanged. Histological analysis corroborated lesion reduction, confirming extract's impact on lesion morphology without altering VEGF or BDNF. CONCLUSION: The hypothesized involvement of VEGF and BDNF was not supported by the data. The principal finding is a reduction in lesion size, with the underlying mechanism remaining uncertain and potentially independent of VEGF/BDNF modulation.
Full text 1,690 characters · extracted from oa-html · click to expand
Publication International Journal of Reproductive BioMedicine (IJRM) Record type Journal article Published 14 July 2026 Authors Fitrianti Umayroh Mahardika | Hendy Hendarto | Widjiati The publisher of this work supports multiple resolution. The work is available from the following locations: {'doi': '10.18502/ijrm.v24i5.21288', 'member_id': '7770', 'member': 'Knowledge E DMCC', 'container-title': 'International Journal of Reproductive BioMedicine (IJRM)', 'primary-resource': 'https://knepublishing.com/index.php/ijrm/article/view/21288', 'tld': 'knepublishing.com', 'clearbit-logo': '/static/no_logo.svg', 'coaccess': [], 'multiple-resolution': [{'url': 'http://ijrm.ir/article-1-3783-en.html', 'tld': 'ijrm.ir', 'clearbit-logo': '/static/no_logo.svg'}], 'type': 'JOURNAL ARTICLE', 'published_date': '14 July 2026', 'publication': 'International Journal of Reproductive BioMedicine (IJRM)', 'title': 'Lesion size reduction in mouse model of endometriosis following clove (Syzygium aromaticum) leaf extract administration: An experimental study', 'name': None, 'id': None, 'location': None, 'display_doi': 'https://doi.org/10.18502/ijrm.v24i5.21288', 'grant_info': None, 'grant_info_funders': None, 'grant_info_funder_ids': '', 'grant_info_type': None, 'multiple_lead_investigators': [], 'multiple_co_lead_investigators': [], 'multiple_investigators': [], 'finances': [], 'project_description': None, 'award_amount': None, 'award_start': None, 'funding_scheme': None, 'internal_award_number': None, 'editors': None, 'authors': 'Fitrianti Umayroh Mahardika | Hendy Hendarto | \u200e Widjiati', 'chairs': None, 'supplementary_ids': None} https://doi.org/10.18502/ijrm.v24i5.21288 JSON XML

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

SciLite annotations

organisms 7
transgenic mice syzygium aromaticum syzygium aromaticum mus sp. enterobacteriaceae bacterium c/sb65 syzygium aromaticum syzygium aromaticum
chemicals 1
estrogen

Source provenance

europepmc
last seen: 2026-09-12T06:55:35.949492+00:00
openalex
last seen: 2026-09-12T06:45:54.676558+00:00
pubmed
last seen: 2026-09-12T06:47:52.879492+00:00
scilite
last seen: 2026-08-09T09:47:33.675890+00:00
License: CC0 · commercial use OK